122 related articles for article (PubMed ID: 22933127)
1. Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics.
Zhang N; Yang J; Chow SC; Endrenyi L; Chi E
Stat Med; 2013 Feb; 32(3):424-33. PubMed ID: 22933127
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of biosimilarity index based on reproducibility probability for assessing follow-on biologics.
Hsieh TC; Chow SC; Yang LY; Chi E
Stat Med; 2013 Feb; 32(3):406-14. PubMed ID: 22899403
[TBL] [Abstract][Full Text] [Related]
3. An adapted F-test for homogeneity of variability in follow-on biological products.
Yang J; Zhang N; Chow SC; Chi E
Stat Med; 2013 Feb; 32(3):415-23. PubMed ID: 22933180
[TBL] [Abstract][Full Text] [Related]
4. Scientific considerations for assessing biosimilar products.
Chow SC; Wang J; Endrenyi L; Lachenbruch PA
Stat Med; 2013 Feb; 32(3):370-81. PubMed ID: 22933240
[TBL] [Abstract][Full Text] [Related]
5. Estimation and approximation approaches for biosimilar index based on reproducibility probability.
Yang LY; Lai CH
J Biopharm Stat; 2014; 24(6):1298-311. PubMed ID: 25033191
[TBL] [Abstract][Full Text] [Related]
6. Statistical assessment of biosimilarity based on relative distance between follow-on biologics.
Kang SH; Chow SC
Stat Med; 2013 Feb; 32(3):382-92. PubMed ID: 22941672
[TBL] [Abstract][Full Text] [Related]
7. Nonparametric tests for evaluation of biosimilarity in variability of follow-on biologics.
Zhang N; Yang J; Chow SC; Chi E
J Biopharm Stat; 2014; 24(6):1239-53. PubMed ID: 25036940
[TBL] [Abstract][Full Text] [Related]
8. Comparability of critical quality attributes for establishing biosimilarity.
Liao JJ; Darken PF
Stat Med; 2013 Feb; 32(3):462-9. PubMed ID: 22903263
[TBL] [Abstract][Full Text] [Related]
9. Comments on the FDA draft guidance on biosimilar products.
Chow SC; Endrenyi L; Lachenbruch PA
Stat Med; 2013 Feb; 32(3):364-9. PubMed ID: 22903309
[TBL] [Abstract][Full Text] [Related]
10. Statistical methods for assessing interchangeability of biosimilars.
Chow SC; Yang LY; Starr A; Chiu ST
Stat Med; 2013 Feb; 32(3):442-8. PubMed ID: 22899372
[TBL] [Abstract][Full Text] [Related]
11. Statistical test for evaluation of biosimilarity in variability of follow-on biologics.
Hsieh TC; Chow SC; Liu JP; Hsiao CF; Chi E
J Biopharm Stat; 2010 Jan; 20(1):75-89. PubMed ID: 20077250
[TBL] [Abstract][Full Text] [Related]
12. Statistical considerations in biosimilar clinical efficacy trials with asymmetrical margins.
Li Y; Liu Q; Wood P; Johri A
Stat Med; 2013 Feb; 32(3):393-405. PubMed ID: 22991275
[TBL] [Abstract][Full Text] [Related]
13. Frequency estimator for assessing of follow-on biologics.
Lu Y; Zhang ZZ; Chow SC
J Biopharm Stat; 2014; 24(6):1280-97. PubMed ID: 25072640
[TBL] [Abstract][Full Text] [Related]
14. Scientific factors and current issues in biosimilar studies.
Chow SC; Endrenyi L; Lachenbruch PA; Mentré F
J Biopharm Stat; 2014; 24(6):1138-53. PubMed ID: 25098559
[TBL] [Abstract][Full Text] [Related]
15. On the interchangeability of biologic drug products.
Endrenyi L; Chang C; Chow SC; Tothfalusi L
Stat Med; 2013 Feb; 32(3):434-41. PubMed ID: 22911936
[TBL] [Abstract][Full Text] [Related]
16. A comparison of moment-based and probability-based criteria for assessment of follow-on biologics.
Chow SC; Hsieh TC; Chi E; Yang J
J Biopharm Stat; 2010 Jan; 20(1):31-45. PubMed ID: 20077247
[TBL] [Abstract][Full Text] [Related]
17. Comparability and biosimilarity: considerations for the healthcare provider.
Lee JF; Litten JB; Grampp G
Curr Med Res Opin; 2012 Jun; 28(6):1053-8. PubMed ID: 22519391
[TBL] [Abstract][Full Text] [Related]
18. Statistical methods for assessment of biosimilarity using biomarker data.
Chow SC; Lu Q; Tse SK; Chi E
J Biopharm Stat; 2010 Jan; 20(1):90-105. PubMed ID: 20077251
[TBL] [Abstract][Full Text] [Related]
19. Application of the parallel line assay to assessment of biosimilar products based on binary endpoints.
Lin JR; Chow SC; Chang CH; Lin YC; Liu JP
Stat Med; 2013 Feb; 32(3):449-61. PubMed ID: 22911920
[TBL] [Abstract][Full Text] [Related]
20. Assessing biosimilarity and interchangeability of biosimilar products.
Chow SC
Stat Med; 2013 Feb; 32(3):361-3. PubMed ID: 23307569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
